Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kindly MD ( (NAKA) ) has issued an update.
On December 10, 2025, Kindly MD, Inc. received a notice from Nasdaq indicating non-compliance with the listing rule due to its stock price falling below $1.00 per share for 30 consecutive days. The company has until June 8, 2026, to regain compliance by ensuring its stock price closes at or above $1.00 for at least 10 consecutive days. If unable to comply, Kindly MD may transfer to the Nasdaq Capital Market, subject to certain conditions, to avoid delisting.
The most recent analyst rating on (NAKA) stock is a Buy with a $1.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
Spark’s Take on NAKA Stock
According to Spark, TipRanks’ AI Analyst, NAKA is a Underperform.
The overall stock score of 38 reflects significant financial and technical challenges. The company’s financial performance is weak, with declining revenues and profitability issues. Technical analysis indicates bearish momentum, and valuation metrics are unattractive due to negative earnings. These factors collectively contribute to a low stock score.
To see Spark’s full report on NAKA stock, click here.
More about Kindly MD
Average Trading Volume: 26,359,631
Technical Sentiment Signal: Sell
Learn more about NAKA stock on TipRanks’ Stock Analysis page.